CYP4A11
Cytochrome P450 4A11
Also known as: CP4AB_HUMAN, CYP4A2, CYP4AII
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02928
- Gene
- CYP4A11
- Ensembl
- ENSG00000187048
- Chromosome
- 1
- Canonical length
- 519 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates medium-chain fatty acids such as laurate and myristate. Multiple transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
519 residues, UniProt reviewed canonical sequence.
>Q02928|CYP4A11
1 MSVSVLSPSR LLGDVSGILQ AASLLILLLL LIKAVQLYLH RQWLLKALQQ FPCPPSHWLF
61 GHIQELQQDQ ELQRIQKWVE TFPSACPHWL WGGKVRVQLY DPDYMKVILG RSDPKSHGSY
121 RFLAPWIGYG LLLLNGQTWF QHRRMLTPAF HYDILKPYVG LMADSVRVML DKWEELLGQD
181 SPLEVFQHVS LMTLDTIMKC AFSHQGSIQV DRNSQSYIQA ISDLNNLVFS RVRNAFHQND
241 TIYSLTSAGR WTHRACQLAH QHTDQVIQLR KAQLQKEGEL EKIKRKRHLD FLDILLLAKM
301 ENGSILSDKD LRAEVDTFMF EGHDTTASGI SWILYALATH PKHQERCREE IHSLLGDGAS
361 ITWNHLDQMP YTTMCIKEAL RLYPPVPGIG RELSTPVTFP DGRSLPKGIM VLLSIYGLHH
421 NPKVWPNPEV FDPFRFAPGS AQHSHAFLPF SGGSRNCIGK QFAMNELKVA TALTLLRFEL
481 LPDPTRIPIP IARLVLKSKN GIHLRLRRLP NPCEDKDQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP4A11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 795 nTPM
Expression across tissuesHPA
Tissue
- liver: 795 nTPM
- kidney: 203 nTPM
- duodenum: 1.4 nTPM
- epididymis: 1.3 nTPM
- small intestine: 1.1 nTPM
- gallbladder: 1 nTPM
Single-cell type
- hepatocytes: 679 nCPM
- proximal tubule cells: 157 nCPM
- epicardial cells: 39 nCPM
- cholangiocytes: 32 nCPM
- fibro-adipogenic progenitors: 8.8 nCPM
- adipocytes: 5.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 1 nTPM
- medulla oblongata: 0.6 nTPM
- pons: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- hypothalamus: 0.5 nTPM
- spinal cord: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.64
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.12
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate metabolic process
- epoxygenase P450 pathway
- fatty acid metabolic process
- icosanoid biosynthetic process
- kidney development
- lauric acid metabolic process
- leukotriene metabolic process
- linoleic acid metabolic process
- long-chain fatty acid metabolic process
- omega-hydroxylase P450 pathway
- oxylipin biosynthetic process
- positive regulation of icosanoid secretion
- pressure natriuresis
- renal water homeostasis
- sodium ion homeostasis
Molecular functions
- alkane 1-monooxygenase activity
- arachidonate epoxygenase activity
- arachidonate monooxygenase activity
- arachidonate omega-hydroxylase activity
- heme binding
- iron ion binding
- leukotriene-B4 20-monooxygenase activity
- long-chain fatty acid omega-hydroxylase activity
- monooxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP4A11 as an antibody target. Whether an autoantibody or antibody against CYP4A11 could matter depends on whether native CYP4A11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP4A11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP4A11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...